Reduction in severity and mortality in COVID-19 patients owing to heterologous third and fourth-dose vaccines during the periods of delta and omicron predominance in Thailand

OBJECTIVES: The COVID-19 pandemic has evolved quickly, with different variants of concern resulting in the need for countries to offer booster vaccinations. Although studies have assessed homologous schedules in detail, the effectiveness of heterologous booster vaccine schedules against severity and...

Descripción completa

Detalles Bibliográficos
Autores principales: Intawong, Kannikar, Chariyalertsak, Suwat, Chalom, Kittipan, Wonghirundecha, Thanachol, Kowatcharakul, Woravut, Ayood, Pisittawoot, Thongprachum, Aksara, Chotirosniramit, Narain, Noppakun, Kajohnsak, Khwanngern, Krit, Teacharak, Worachet, Piamanant, Prapon, Khammawan, Pimpinan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650516/
https://www.ncbi.nlm.nih.gov/pubmed/36372363
http://dx.doi.org/10.1016/j.ijid.2022.11.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650516/
https://www.ncbi.nlm.nih.gov/pubmed/36372363
http://dx.doi.org/10.1016/j.ijid.2022.11.006

Ejemplares similares